High-dose fluticasone increases sputum bacterial load in severe COPD; ICS withdrawal is poorly tolerated, highlighting ...
If you start to experience symptoms like chest pain, blue lips, or coughing up more than a teaspoon of blood, you should see ...
Samay founder and CEO Dr. Maria Artunduaga says things changed pretty quickly for her startup after winning the MedTech ...
Previous non-experimental studies suggest an association between paracetamol exposure in the first year of life and subsequent asthma and eczema developing in childhood; however, randomised trials are ...
A new study published in The American Journal of Medicine found tirzepatide, which is prescribed for diabetes and weight ...
Patients with chronic obstructive pulmonary disease (COPD) face a significant cardiovascular burden both before and after diagnosis. Analyses presented at the European Respiratory Society (ERS) ...
Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in ...
Congress demonstrated that just under 50% of people assessed through the FRONTIER Hull Programme were diagnosed with chronic obstructive pulmonary disease (COPD) following a previous assessment via ...
The presentations will be available on Connect’s website under the publications and presentations section.
The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared ...
A phase 3 trial evaluating benralizumab for the treatment of COPD did not meet its primary endpoint, according to AstraZeneca.
C hronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition—primarily chronic bronchitis and emphysema—characterised by persistent respiratory symptoms and airflow limitation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback